Related Experiment Video
Updated: Apr 19, 2026

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
Published on: October 3, 2010
Salinomycin Suppresses PDGFRβ, MYC, and Notch Signaling in Human Medulloblastoma
Shuang Zhou1, Fengfei Wang1, Ying Zhang1
1Department of Pharmaceutical Sciences, North Dakota State University, USA.
Abstract:
Medulloblastoma (MB) is the most common childhood brain tumor. Despite improved therapy and management, approximately 30% of patients die of the disease. To search for a more effective therapeutic strategy, the effects of salinomycin were tested on cell proliferation, cell death, and cell cycle progression in human MB cell lines. The results demonstrated that salinomycin inhibits cell proliferation, induces cell death , and disrupts cell cycle progression in MB cells. Salinomycin was also tested on the expression levels of key genes involved in proliferation and survival signaling and revealed that salinomycin down-regulates the expression of PDGFRβ, MYC, p21 and Bcl-2 as well as up-regulates the expression of cyclin A. In addition, the results reveal that salinomycin suppresses the expression of Hes1 and Hes5 in MB cells. Our data shed light on the potential of using salinomycin as a novel therapeutic agent for patients with MB.
Insights
Salinomycin effectively combats medulloblastoma (MB), the most common childhood brain tumor. This compound inhibits MB cell growth, triggers cell death, and alters cell cycle progression, offering a promising new therapeutic avenue.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Medulloblastoma (MB) is the most prevalent pediatric brain tumor.
- Current treatments have limitations, with a significant mortality rate of approximately 30%.
Purpose of the Study:
- To investigate the therapeutic potential of salinomycin against human MB cell lines.
- To evaluate salinomycin's effects on MB cell proliferation, cell death, and cell cycle progression.
Main Methods:
- Treatment of human MB cell lines with salinomycin.
- Assessment of cell proliferation, cell death, and cell cycle distribution.
- Analysis of gene expression changes related to proliferation and survival signaling pathways.
Main Results:
- Salinomycin significantly inhibited MB cell proliferation and induced cell death.
- Salinomycin disrupted normal cell cycle progression in MB cells.
- Key gene expression changes included down-regulation of PDGFRβ, MYC, p21, Bcl-2, Hes1, and Hes5, and up-regulation of cyclin A.
Conclusions:
- Salinomycin demonstrates potent anti-cancer activity in medulloblastoma models.
- The drug affects critical pathways regulating cell growth and survival.
- Salinomycin shows promise as a novel therapeutic agent for MB patients.
More Related Videos
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Abnormal Proliferation
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

